Mgen Solutions Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 03:41 am EST
Share
Mgen Solutions Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 43.9 million compared to KRW 410.04 million a year ago. Net income was KRW 447.85 million compared to KRW 5,581.72 million a year ago. Basic earnings per share from continuing operations was KRW 16 compared to KRW 197 a year ago. Diluted earnings per share from continuing operations was KRW 16 compared to KRW 197 a year ago. Basic earnings per share was KRW 15 compared to KRW 193 a year ago. Diluted earnings per share was KRW 15 compared to KRW 193 a year ago.
For the nine months, sales was KRW 125.31 million compared to KRW 728.46 million a year ago. Net income was KRW 2,965.32 million compared to KRW 5,098.32 million a year ago. Basic earnings per share from continuing operations was KRW 112 compared to KRW 204 a year ago. Diluted earnings per share from continuing operations was KRW 112 compared to KRW 204 a year ago. Basic earnings per share was KRW 100 compared to KRW 201 a year ago. Diluted earnings per share was KRW 100 compared to KRW 201 a year ago.
Mgen Solutions Co Ltd, formerly BNGT Co Ltd, is a Korea-based company engaged in the manufacture and sale of printer cartridge parts. The Company operates its business through five segments. The Developing Machine Business segment is engaged in the manufacture and sale of printer cartridge parts. The Broadband Convergence Network (BcN)/Artificial Intelligence (AI) Business segment is engaged in the operation and build of broadband self-communication network. The Segment is also engaged in the provision of artificial intelligence image analysis solutions. The Communication Network Business segment is engaged in the provision of information technology services related to smart homes and the Internet of Things (IoT). The Bio Business segment is engaged in the development of organs for transplantation. The Other Business segment is engaged in the sale of medical devices.